Schwangerschaft und Stillen mit chronisch entzündlichen Darmerkrankungen

Die Erstmanifestation chronisch entzündlicher Darmerkrankungen (CED) tritt häufig im jungen Erwachsenenalter auf – einem Lebensabschnitt, der auch mit dem Wunsch nach Kindern verbunden ist. Dieser Beitrag bietet Argumentationshilfen für das Gespräch mit CED-Erkrankten mit Kinderwunsch, insbesondere für häufig gestellte Fragen zur medikamentösen Therapie. Der Schwerpunkt liegt auf Aspekten, deren Bewertung sich in den letzten Jahren verändert hat.

Schlüsselwörter

Morbus Crohn - Colitis ulcerosa - Schwangerschaft - Stillzeit - Endoskopie

• Literatur

• 1 Mountifield R, Bampton P, Prosser R. et al. Fear and fertility in inflammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis 2009; 15: 720-725
• 2 Timmer A, Kemptner D, Bauer A. et al. Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis. BMC Gastroenterol 2008; 8: 45
• 3 Mahadevan U, Sandborn WJ, Li DK. et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007; 133: 1106-1112
• 4 de Lima A, Zelinkova Z, Mulders AG. et al. Preconception care reduces relapse of inflammatory bowel disease during pregnancy. Clin Gastroenterol Hepatol 2016; 14: 1285-1292
• 5 U.S. Food and Drug Administration, Drugs.com. Pregnant? Breastfeeding? Better Drug Information Is Coming. 2014 Im Internet: http://www.drugs.com/fda-consumer/pregnant-breastfeeding-better-drug-information-is-coming-334.html Stand: 03.08.2017
• 6 Colombel JF, Brabant G, Gubler MC. et al. Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine?. Lancet 1994; 344: 620-621
• 7 Nørgård B, Czeizel AE, Rockenbauer M. et al. Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001; 15: 483-486
• 8 Beaulieu DB, Ananthakrishnan AN, Issa M. et al. Budesonide induction and maintenance therapy for Crohnʼs disease during pregnancy. Inflamm Bowel Dis 2009; 15: 25-28
• 9 de Meij TG, Jharap B, Kneepkens CM et al.; Dutch Initiative on Crohn and Colitis. Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease. Aliment Pharmacol Ther 2013; 38: 38-43
• 10 Kozlowski RD, Steinbrunner JV, MacKenzie AH. et al. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 1990; 88: 589-592
• 11 Martínez Lopez JA, Loza E, Carmona L. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding). Clin Exp Rheumatol 2009; 27: 678-684
• 12 van der Woude CJ, Ardizzone S, Bengtson MB. et al. European Crohnʼs and Colitis Organization. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis 2015; 9: 107-124
• 13 Julsgaard M, Christensen LA, Gibson PR. et al. Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology 2016; 151: 110-119
• 14 Nguyen GC, Seow CH, Maxwell C. et al. IBD in Pregnancy Consensus Group; Canadian Association of Gastroenterology. The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy. Gastroenterology 2016; 150: 734-757
• 15 Mahadevan U, Vermeire S, Lasch K. et al. Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease. Aliment Pharmacol Ther 2017; 45: 941-950
• 16 Cortes X, Borrás-Blasco J, Antequera B. et al. Ustekinumab therapy for Crohnʼs disease during pregnancy: a case report and review of the literature. J Clin Pharm Ther 2017; 42: 234-236
• 17 Sato A, Naganuma M, Asakura K. et al. Conception outcomes and opinions about pregnancy for men with inflammatory bowel disease. J Crohns Colitis 2010; 4: 183-188
• 18 Shin T, Okada H. Infertility in men with inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7: 361-369
• 19 de Lima A, Zelinkova Z, van der Woude CJ. A prospective study of the safety of lower gastrointestinal endoscopy during pregnancy in patients with inflammatory bowel disease. J Crohns Colitis 2015; 9: 519-524
• 20 Kahaleh M, Hartwell GD, Arseneau KO. et al. Safety and efficacy of ERCP in pregnancy. Gastrointest Endosc 2004; 60: 287-292
• 21 Farca A, Aguilar ME, Rodriguez G. et al. Biliary stents as temporary treatment for choledocholithiasis in pregnant patients. Gastrointest Endosc 1997; 46: 99-101
• 22 Freud A, Beharier O, Walfisch A. et al. Maternal inflammatory bowel disease during pregnancy is not a risk factor for long-term morbidity of the offspring. J Crohns Colitis 2016; 10: 1267-1272